ALB and psoriasis: Patients with severe psoriasis have also been found to have greater levels of advanced glycation end products in their blood and skin, like glycated albumin, hemoglobin, and fibrinogen, which in turn alters intracellular signaling pathways leading to the release of inflammatory molecules and free radicles with worse outcomes [25].